ATS/Smith & Nephew
This article was originally published in The Gray Sheet
Executive Summary
Equity ownership position in Advanced Tissue Sciences by S&N more than doubles to about 8% with the conversion of a $10 mil. loan into about 2.8 mil. common stock shares. The loan was originally made in connection with a joint venture for development of Dermagraft tissue engineering technology for diabetic foot ulcers